Nobilis Health Corp. Stock Price, News & Analysis (NYSEAMERICAN:HLTH)

$1.45 0.00 (0.00 %)
(As of 11/18/2017 04:00 PM ET)
Previous Close$1.45
Today's Range$1.40 - $1.50
52-Week Range$1.10 - $3.05
Volume410,790 shs
Average Volume282,887 shs
Market Capitalization$112.82 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.82

About Nobilis Health Corp. (NYSEAMERICAN:HLTH)

Nobilis Health Corp. logoNobilis Health Corp. (Nobilis) owns and manages healthcare facilities in the States of Texas and Arizona, consisting primarily of ambulatory surgery centers (ASCs) and acute-care and surgical hospitals. The Company's segments include Medical Services, Marketing Services and Corporate. The Medical Services segment owns and manages approximately nine healthcare facilities in Texas and Arizona; over four hospitals, and approximately five ambulatory surgery centers. The Marketing Services segment provides marketing services, patient education services and patient care co-ordination management services. The Company provides care across a range of specialties in its facilities, including orthopedic surgery, podiatric surgery, pain management, gastro-intestinal, gynecology, and general surgery. Many of its surgical patients require additional complementary healthcare services, and its suite of ancillary services, including surgical assist, intraoperative neuromonitoring and anesthesia.


Industry, Sector and Symbol:
  • Industry: Healthcare Facilities & Services
  • Sub-Industry: N/A
  • Sector: N/A
  • Symbol: NYSEAMERICAN:HLTH
  • Previous Symbol: NYSE:HLTH
  • CUSIP: N/A
  • Web: www.northstar-healthcare.com
Misc:
  • Outstanding Shares: 77,810,000
 

Frequently Asked Questions for Nobilis Health Corp. (NYSEAMERICAN:HLTH)

What is Nobilis Health Corp.'s stock symbol?

Nobilis Health Corp. trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "HLTH."

How will Nobilis Health Corp.'s stock buyback program work?

Nobilis Health Corp. announced that its board has authorized a share buyback program on Wednesday, November 15th 2017, which allows the company to repurchase 4,000,000 outstanding shares, according to EventVestor. This repurchase authorization allows the company to buy shares of its stock through open market purchases. Stock repurchase programs are generally a sign that the company's board of directors believes its stock is undervalued.

How were Nobilis Health Corp.'s earnings last quarter?

Nobilis Health Corp. (NYSEAMERICAN:HLTH) announced its quarterly earnings results on Monday, November, 6th. The healthcare company reported $0.01 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.04 by $0.03. The healthcare company had revenue of $64.70 million for the quarter, compared to analyst estimates of $78.29 million. The business's revenue for the quarter was down 8.5% on a year-over-year basis. During the same period last year, the business earned ($0.04) earnings per share. View Nobilis Health Corp.'s Earnings History.

When will Nobilis Health Corp. make its next earnings announcement?

Nobilis Health Corp. is scheduled to release their next quarterly earnings announcement on Monday, March, 12th 2018. View Earnings Estimates for Nobilis Health Corp..

Where is Nobilis Health Corp.'s stock going? Where will Nobilis Health Corp.'s stock price be in 2017?

3 Wall Street analysts have issued 1 year price targets for Nobilis Health Corp.'s shares. Their forecasts range from $2.00 to $2.50. On average, they anticipate Nobilis Health Corp.'s stock price to reach $2.25 in the next twelve months. View Analyst Ratings for Nobilis Health Corp..

Are investors shorting Nobilis Health Corp.?

Nobilis Health Corp. saw a drop in short interest in the month of October. As of October 31st, there was short interest totalling 3,137,212 shares, a drop of 10.0% from the October 13th total of 3,486,276 shares. Based on an average daily volume of 212,492 shares, the days-to-cover ratio is presently 14.8 days. Currently, 5.6% of the shares of the stock are short sold.

Who are some of Nobilis Health Corp.'s key competitors?

Who owns Nobilis Health Corp. stock?

Nobilis Health Corp.'s stock is owned by a variety of of retail and institutional investors. Top institutional investors include Russell Investments Group Ltd. (73,425,100.00%) and Macquarie Group Ltd. (49,863,300.00%). Company insiders that own Nobilis Health Corp. stock include Donald Louis Kramer, Harry Joseph Fleming, Jennifer Hauser, Kenneth Efird, Kenneth Joseph Klein, Marcos Alberto Rodriguez, Matthew Keavney Maruca, Paul David Young, Peter Horan and Richard Ganley. View Institutional Ownership Trends for Nobilis Health Corp..

Who bought Nobilis Health Corp. stock? Who is buying Nobilis Health Corp. stock?

Nobilis Health Corp.'s stock was acquired by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd. and Macquarie Group Ltd.. Company insiders that have bought Nobilis Health Corp. stock in the last two years include Donald Louis Kramer, Harry Joseph Fleming, Jennifer Hauser, Kenneth Efird, Kenneth Joseph Klein, Marcos Alberto Rodriguez, Matthew Keavney Maruca, Paul David Young, Peter Horan and Richard Ganley. View Insider Buying and Selling for Nobilis Health Corp..

How do I buy Nobilis Health Corp. stock?

Shares of Nobilis Health Corp. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Nobilis Health Corp.'s stock price today?

One share of Nobilis Health Corp. stock can currently be purchased for approximately $1.45.

How big of a company is Nobilis Health Corp.?

Nobilis Health Corp. has a market capitalization of $112.82 million.

How can I contact Nobilis Health Corp.?

Nobilis Health Corp.'s mailing address is 11700 Katy Fwy Ste 300, HOUSTON, TX 77079-1218, United States. The healthcare company can be reached via phone at +1-713-3558614.


MarketBeat Community Rating for Nobilis Health Corp. (NYSEAMERICAN HLTH)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  85 (Vote Outperform)
Underperform Votes:  94 (Vote Underperform)
Total Votes:  179
MarketBeat's community ratings are surveys of what our community members think about Nobilis Health Corp. and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Nobilis Health Corp. (NYSEAMERICAN:HLTH)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 2 Hold Ratings, 1 Buy Rating, 0 Strong Buy Ratings
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $2.25

Consensus Price Target History for Nobilis Health Corp. (NYSEAMERICAN:HLTH)

Price Target History for Nobilis Health Corp. (NYSEAMERICAN:HLTH)

Analysts' Ratings History for Nobilis Health Corp. (NYSEAMERICAN:HLTH)

Show:
DateFirmActionRatingPrice TargetDetails
5/19/2017Benchmark Co.Initiated CoverageBuy -> Buy$2.50View Rating Details
3/13/2017Pi FinancialDowngradeBuy -> NeutralView Rating Details
12/12/2016Craig HallumDowngradeBuy -> Hold$6.00 -> $2.00View Rating Details
9/19/2016Canaccord GenuitySet Price TargetBuy$4.80View Rating Details
(Data available from 11/19/2015 forward)

Earnings

Earnings History and Estimates Chart for Nobilis Health Corp. (NYSEAMERICAN:HLTH)

Earnings by Quarter for Nobilis Health Corp. (NYSEAMERICAN:HLTH)

Earnings History by Quarter for Nobilis Health Corp. (NYSEAMERICAN HLTH)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/12/2018        
11/6/2017Q3 2017$0.04$0.01$78.29 million$64.70 millionViewN/AView Earnings Details
8/2/2017Q2 2017$0.01$0.02$69.89 million$79.96 millionViewListenView Earnings Details
5/2/2017Q1 2017($0.10)($0.02)$56.30 million$68.30 millionViewListenView Earnings Details
3/13/2017Q4 2016$0.36$0.12$100.11 million$101.90 millionViewN/AView Earnings Details
11/7/2016Q316$0.07($0.04)$65.75 million$70.70 millionViewListenView Earnings Details
8/2/2016Q216$0.01$0.06$62.18 million$61.90 millionViewN/AView Earnings Details
8/14/2015Q215($0.03)($0.02)$42.20 million$48.90 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Nobilis Health Corp. (NYSEAMERICAN:HLTH)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Nobilis Health Corp. (NYSEAMERICAN:HLTH)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Nobilis Health Corp. (NYSEAMERICAN HLTH)

Insider Trades by Quarter for Nobilis Health Corp. (NYSEAMERICAN:HLTH)
Institutional Ownership by Quarter for Nobilis Health Corp. (NYSEAMERICAN:HLTH)

Insider Trades by Quarter for Nobilis Health Corp. (NYSEAMERICAN HLTH)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/26/2017Paul David YoungCFOBuy10,000$1.40$14,000.00View SEC Filing  
3/23/2017Harry Joseph FlemingCEOBuy25,000$1.69$42,250.00View SEC Filing  
3/21/2017Harry Joseph FlemingCEOBuy25,000$1.75$43,750.00View SEC Filing  
3/17/2017Harry Joseph FlemingCEOBuy25,000$1.70$42,500.00View SEC Filing  
3/17/2017Marcos Alberto RodriguezInsiderBuy3,500$1.70$5,950.00View SEC Filing  
12/20/2016Peter HoranDirectorBuy5,000$1.90$9,500.00View SEC Filing  
2/16/2016Donald Louis KramerMajor ShareholderBuy20,000$2.08$41,600.00View SEC Filing  
2/12/2016Donald Louis KramerMajor ShareholderBuy20,000$1.97$39,400.00View SEC Filing  
2/4/2016Harry Joseph FlemingCEOBuy10,000$2.38$23,800.00View SEC Filing  
2/3/2016Harry Joseph FlemingCEOBuy10,000$2.22$22,200.00View SEC Filing  
2/2/2016Harry Joseph FlemingCEOBuy10,000$2.20$22,000.00View SEC Filing  
2/1/2016Kenneth Joseph KleinCFOBuy5,000$2.16$10,800.00View SEC Filing  
1/29/2016Harry Joseph FlemingCEOBuy31,700$1.99$63,083.00View SEC Filing  
1/29/2016Jennifer HauserDirectorBuy9,137$1.97$17,999.89View SEC Filing  
1/29/2016Kenneth EfirdCOOBuy11,900$2.08$24,752.00View SEC Filing  
1/29/2016Matthew Keavney MarucaInsiderBuy2,300$2.07$4,761.00View SEC Filing  
1/26/2016Jennifer HauserDirectorBuy8,700$2.06$17,922.00View SEC Filing  
1/22/2016Richard GanleyDirectorBuy10,000$2.11$21,100.00View SEC Filing  
9/11/2015Richard GanleyDirectorBuy5,000$4.50$22,500.00View SEC Filing  
8/21/2015Richard GanleyDirectorBuy5,300$4.66$24,698.00View SEC Filing  
6/18/2015Richard GanleyDirectorBuy6,000$6.58$39,480.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Nobilis Health Corp. (NYSEAMERICAN HLTH)

Source:
DateHeadline
Share Repurchase Plan Authorized by Nobilis Health Corp (HLTH) Share Repurchase Plan Authorized by Nobilis Health Corp (HLTH)
www.americanbankingnews.com - November 15 at 12:38 PM

Social Media

Social activity is not available for this stock.

Financials

Chart

Nobilis Health Corp. (NYSEAMERICAN HLTH) Chart for Sunday, November, 19, 2017
Loading chart…

This page was last updated on 11/19/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.